SMAD4 plays a key role in regulating TGF-β–induced collagen expression and promotes SMAD3-mediated renal fibrosis (57) while activation of EGFR serves as prognostic biomarker during chronic kidney disease (58). Here, SMAD4 is linked to renal fibrosis.